TMCI · TREACE MEDICAL CONCEPTS, INC.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Cap structure and valuation

Cap structure
SP	$4.37
SO	65.0M
Options	7.2M
Warrants	0.0M
FD SO	72.2M
MC	$315.5M

Cash	$12.6M
Total debt	$56.0M
EV	$358.9M

TTM Multiples
EV / Revenue	1.7x
EV / EBITDA	—
MC / Net Income	—
EV / FCF	—
MC / FCF	—

Ownership & coverage
Institutional	49.7%
Insiders	25.2%
# Institutions	153
Analysts	3
Consensus	Hold
Avg target	$5.50

Short % float	3.3%
Days to cover	3.84

MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-07-31. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-08-25 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-07-31; the float denominator can be unreliable on tiny floats.

Financial statements

	6/30/26	3/31/26	12/31/25	9/30/25
Total Revenue	45.38	47.20	62.52	50.21
Revenue YoY %	(4.2%)	(10.2%)	(9.0%)	11.4%
Cost of Revenue	9.77	9.79	12.12	10.51
Gross Profit	35.61	37.41	50.40	39.71
Gross Profit YoY %	(5.7%)	(10.7%)	(9.1%)	9.9%
Gross Margin %	78.5%	79.3%	80.6%	79.1%

SG&A	46.19	49.95	51.78	50.70
R&D	4.38	4.62	4.54	4.68
Operating Expense	50.56	54.57	56.32	55.38

Operating Income	(14.96)	(17.17)	(5.92)	(15.68)
Operating Income YoY %	11.9%	(10.2%)	(2802.9%)	(3.6%)
Operating Margin %	(33.0%)	(36.4%)	(9.5%)	(31.2%)
EBITDA	(13.07)	(16.27)	(3.11)	(12.90)
EBITDA Margin %	(28.8%)	(34.5%)	(5.0%)	(25.7%)

Interest Expense	1.56	1.57	1.35	1.34
Other Income / (Expense)	0.65	0.78	(2.12)	0.73
Pretax Income	(15.87)	(17.96)	(9.39)	(16.29)
Tax Provision	—	—	0.00	—
Net Income	(15.87)	(17.96)	(9.39)	(16.29)
Net Margin %	(35.0%)	(38.1%)	(15.0%)	(32.4%)

Diluted EPS	-$0.24	-$0.28	-$0.14	-$0.26
Basic EPS	-$0.24	-$0.28	-$0.14	-$0.26
Diluted Avg Shares	65.0	64.6	—	63.5
Basic Avg Shares	65.0	64.6	—	63.5

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Total Revenue	205.31	212.69	209.36	187.12	141.84
Revenue YoY %	(3.5%)	1.6%	11.9%	31.9%	—
Cost of Revenue	42.19	42.94	41.09	35.18	25.53
Gross Profit	163.12	169.75	168.26	151.94	116.31
Gross Profit YoY %	(3.9%)	0.9%	10.7%	30.6%	—
Gross Margin %	79.5%	79.8%	80.4%	81.2%	82.0%

SG&A	198.62	203.62	203.36	187.93	137.57
R&D	18.22	20.28	20.59	15.44	13.58
Operating Expense	216.84	223.91	223.95	203.37	151.15

Operating Income	(53.72)	(54.15)	(55.69)	(51.43)	(34.84)
Operating Income YoY %	0.8%	2.8%	(8.3%)	(47.6%)	—
Operating Margin %	(26.2%)	(25.5%)	(26.6%)	(27.5%)	(24.6%)
EBITDA	(45.35)	(43.53)	(47.27)	(46.08)	(32.71)
EBITDA Margin %	(22.1%)	(20.5%)	(22.6%)	(24.6%)	(23.1%)

Interest Expense	5.82	5.32	5.26	5.17	4.40
Other Income / (Expense)	—	—	5.20	7.07	(3.57)
Pretax Income	(59.52)	(59.00)	(55.74)	(49.53)	(42.81)
Tax Provision	—	0.00	0.00	0.00	0.00
Net Income	(59.52)	(59.00)	(55.74)	(49.53)	(42.81)
Net Income to Common	(59.52)	(59.00)	(55.74)	(50.00)	(43.00)
Net Margin %	(29.0%)	(27.7%)	(26.6%)	(26.5%)	(30.2%)

Diluted EPS	-$0.92	-$0.93	-$0.90	-$0.81	-$0.77
Basic EPS	-$0.92	-$0.93	-$0.90	-$0.81	-$0.77
Diluted Avg Shares	65.0	63.3	62.1	60.9	55.3
Basic Avg Shares	65.0	63.3	62.1	60.9	55.3

	6/30/26	3/31/26	12/31/25	9/30/25
Cash & Equivalents	12.61	9.54	10.71	7.69
Short-term Investments	33.01	42.31	37.66	49.73
Receivables	28.73	30.36	42.16	32.96
Inventory	39.54	36.37	36.03	41.42
Other Current Assets	6.56	4.89	5.50	6.20
Total Current Assets	120.45	123.47	132.05	138.00

Net PPE	32.50	32.06	29.75	29.97
Operating Lease ROU	7.14	7.37	7.61	7.83
Goodwill	12.81	12.81	12.81	12.81
Intangible Assets	6.65	6.89	7.12	7.36
Other Assets	1.50	1.50	1.22	—
Total Assets	181.06	184.10	190.58	196.59

Accounts Payable	16.06	13.54	6.73	16.10
Current Lease Liabilities	0.39	0.46	0.55	2.12
Other Current Liabilities	25.05	20.50	23.36	22.69
Total Current Liabilities	41.50	34.49	30.64	40.91
Long-term Debt	56.04	55.82	55.58	53.53
Long-term Lease Liabilities	13.09	13.55	13.98	12.93
Other Liabilities	2.69	3.05	3.05	—
Total Liabilities	113.32	106.91	103.25	107.40

Retained Earnings	(282.83)	(266.95)	(248.99)	(239.60)
Total Equity	67.74	77.19	87.33	89.19

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Cash & Equivalents	12.61	10.71	11.35	12.98	19.47
Short-term Investments	33.01	37.66	64.33	110.22	61.78
Receivables	28.73	42.16	40.80	38.10	29.20
Inventory	39.54	36.03	39.26	29.25	19.33
Other Current Assets	6.56	5.50	5.67	7.82	3.62
Total Current Assets	120.45	132.05	161.40	198.36	133.40

Net PPE	32.50	29.75	25.95	22.30	15.34
Operating Lease ROU	7.14	7.61	8.44	9.26	10.14
Goodwill	12.81	12.81	12.81	12.81	0.00
Intangible Assets	6.65	7.12	8.07	9.03	0.00
Other Assets	1.50	1.22	—	—	—
Total Assets	181.06	190.58	217.09	251.91	159.02

Accounts Payable	16.06	6.73	10.52	11.84	8.67
Current Lease Liabilities	0.39	0.55	0.41	1.40	0.34
Other Current Liabilities	25.05	23.36	23.99	31.79	21.24
Total Current Liabilities	41.50	30.64	34.92	45.03	30.25
Long-term Debt	56.04	55.58	53.31	53.01	52.71
Long-term Lease Liabilities	13.09	13.98	15.93	15.89	15.54
Other Liabilities	2.69	3.05	—	—	—
Total Liabilities	113.32	103.25	104.20	113.97	98.50

Retained Earnings	(282.83)	(248.99)	(189.99)	(134.25)	(84.72)
Total Equity	67.74	87.33	112.89	137.94	60.53

	6/30/26	3/31/26	12/31/25	9/30/25
Net Income	(15.87)	(17.96)	(9.39)	(16.29)
D&A	1.89	0.90	2.81	2.78
Stock-Based Comp	6.46	8.03	7.55	8.00
Δ Working Cap & Other	2.82	16.27	(8.99)	(3.58)
Operating Cash Flow	(4.70)	7.24	(8.03)	(9.09)

CapEx	(2.20)	(3.06)	(2.40)	(2.81)
Other Investing	9.27	(4.75)	12.06	11.54
Investing Cash Flow	7.07	(7.82)	9.67	8.74

Other Financing	0.70	(0.59)	1.38	—
Financing Cash Flow	0.70	(0.59)	1.38	(0.01)

Free Cash Flow	(6.90)	4.18	(10.42)	(11.90)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Net Income	(59.52)	(59.00)	(55.74)	(49.53)	(42.81)
D&A	8.37	10.62	8.42	5.35	2.13
Stock-Based Comp	30.05	33.82	30.60	17.35	8.11
Δ Working Cap & Other	6.52	(1.41)	(20.45)	(7.75)	1.92
Operating Cash Flow	(14.58)	(15.97)	(37.17)	(34.58)	(30.65)

CapEx	(10.47)	(13.52)	(11.59)	(11.46)	(14.84)
Acquisitions	—	0.00	0.00	(20.00)	0.00
Other Investing	28.12	26.77	46.97	(49.84)	(61.68)
Investing Cash Flow	17.65	13.25	35.38	(81.30)	(76.52)

Debt Issuance	—	—	—	—	0.00
Debt Repayment	—	—	—	0.00	0.00
Other Financing	1.48	2.08	—	109.38	20.81
Financing Cash Flow	1.48	2.08	0.16	109.38	20.81

Free Cash Flow	(25.05)	(29.49)	(48.76)	(46.03)	(45.49)

	6/30/26	3/31/26	12/31/25	9/30/25
Current Ratio	2.90	3.58	4.31	3.37
Quick Ratio	1.95	2.53	3.13	2.36
Debt / Equity	0.83	0.72	0.64	0.60
EBITDA Margin %	(28.8%)	(34.5%)	(5.0%)	(25.7%)
Working Capital	78.96	88.98	101.42	97.09
Net Debt	43.43	46.28	44.88	45.84
ROE %	(23.4%)	(23.3%)	(10.8%)	(18.3%)
ROA %	(8.8%)	(9.8%)	(4.9%)	(8.3%)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Current Ratio	2.90	4.31	4.62	4.40	4.41
Quick Ratio	1.95	3.13	3.50	3.76	3.77
Debt / Equity	0.83	0.64	0.47	0.38	0.87
EBITDA Margin %	(22.1%)	(20.5%)	(22.6%)	(24.6%)	(23.1%)
Working Capital	78.96	101.42	126.48	153.33	103.16
Net Debt	43.43	44.88	41.96	40.03	33.24
ROE %	(87.9%)	(67.6%)	(49.4%)	(35.9%)	(70.7%)
ROA %	(32.9%)	(31.0%)	(25.7%)	(19.7%)	(26.9%)

Insider activity (last 2 years)

Date Filed	Reporter	Relationship	Trans. Date	Code	Shares	Price	Total Value
2026-08-24	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-08-24	P	11,000	$4.34	$47,731
2026-08-24	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-08-21	P	5,000	$4.35	$21,748
2026-08-24	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-08-20	P	39,944	$4.44	$177,176
2026-08-12	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-08-09	F	(9,814)	—	$-0
2026-08-12	Hair Mark	Officer (Chief Financial Officer)	2026-08-09	F	(37,102)	—	$-0
2026-08-12	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2026-08-09	F	(16,253)	—	$-0
2026-06-12	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-06-11	P	9,891	$4.04	$39,982
2026-06-12	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-06-10	P	14,715	$4.02	$59,213
2026-06-11	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-06-11	P	22,887	$4.04	$92,541
2026-06-11	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-06-10	P	29,430	$4.02	$118,426
2026-06-01	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-06-01	P	50,000	$3.56	$177,915
2026-05-28	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-05-28	P	61,202	$3.02	$184,824
2026-05-28	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-05-27	P	49,810	$2.87	$143,189
2026-05-28	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-05-26	P	4,508	$2.79	$12,576
2026-05-19	BAKEWELL JOHN K	Director	2026-05-19	A	30,000	—	$0
2026-05-19	Kiernan Jane E	Director	2026-05-19	A	30,000	—	$0
2026-05-19	Berry Lance A	Director	2026-05-19	A	30,000	—	$0
2026-05-19	Jain Deepti	Director	2026-05-19	A	30,000	—	$0
2026-05-19	HAMILTON LAWRENCE W	Director	2026-05-19	A	30,000	—	$0
2026-05-19	Hanna Betsy	Director	2026-05-19	A	30,000	—	$0
2026-05-14	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-05-14	P	61,750	$2.62	$161,495
2026-05-14	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-05-13	P	49,013	$2.46	$120,533
2026-05-14	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-05-12	P	43,000	$2.17	$93,478
2026-04-20	Hair Mark	Officer (Chief Financial Officer)	2026-04-17	F	(11,547)	—	$-0
2026-04-03	Hair Mark	Officer (Chief Financial Officer)	2026-04-01	A	100,000	—	$0
2026-03-11	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2026-03-10	F	(1,675)	—	$-0
2026-03-11	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-03-10	F	(1,396)	—	$-0
2026-03-11	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-03-10	F	(5,021)	—	$-0
2026-03-11	Hair Mark	Officer (Chief Financial Officer)	2026-03-10	F	(3,695)	—	$-0
2026-03-11	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2026-03-08	F	(175)	—	$-0
2026-03-11	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-03-08	F	(401)	—	$-0
2026-03-11	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-03-08	F	(2,062)	—	$-0
2026-03-11	Hair Mark	Officer (Chief Financial Officer)	2026-03-08	F	(964)	—	$-0
2026-02-11	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-02-10	M	16,875	$1.05	$17,719
2026-02-11	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-02-10	M	(16,875)	—	$-0
2026-01-23	Guglielmino Gaetano	Officer (Chief Commercial Officer)	2026-01-22	A	150,000	—	$0
2026-01-23	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2026-01-22	F	(9,451)	—	$-0
2026-01-23	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2026-01-22	A	262,500	—	$0
2026-01-23	Hair Mark	Officer (Chief Financial Officer)	2026-01-22	F	(17,037)	—	$-0
2026-01-23	Hair Mark	Officer (Chief Financial Officer)	2026-01-22	A	375,000	—	$0
2026-01-23	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-01-22	A	262,500	—	$0
2026-01-23	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-01-22	F	(14,254)	—	$-0
2026-01-23	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-01-22	A	250,000	—	$0
2026-01-23	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-01-21	M	53,500	$0.72	$38,520
2026-01-23	Scanlan Sean F.	Officer (Chief Innovation Officer)	2026-01-21	M	53,500	—	$0
2026-01-13	Hair Mark	Officer (Chief Financial Officer)	2026-01-10	F	(8,719)	—	$-0
2026-01-13	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2026-01-10	F	(4,544)	—	$-0
2026-01-13	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2026-01-10	F	(13,219)	—	$-0
2025-12-03	Guglielmino Guy	Officer (Chief Commercial Officer)	2025-12-01	F	(20,090)	—	$-0
2025-12-03	Guglielmino Guy	Officer (Chief Commercial Officer)	2025-12-01	F	(2,009)	—	$-0
2025-10-28	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-10-25	F	(984)	—	$-0
2025-10-28	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-10-24	F	(208)	—	$-0
2025-10-02	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-10-02	F	(650)	—	$-0
2025-10-02	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-09-30	F	(16,234)	—	$-0
2025-08-12	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-08-09	F	(10,515)	—	$-0
2025-08-12	Hair Mark	Officer (Chief Financial Officer)	2025-08-09	F	(22,212)	—	$-0
2025-08-12	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-08-09	F	(9,814)	—	$-0
2025-08-12	Berutti Aaron	Officer (SVP, Sales)	2025-08-09	F	(4,907)	—	$-0
2025-07-22	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-07-18	M	33,437	$0.72	$24,001
2025-07-22	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-07-18	M	(33,437)	—	$-0
2025-05-21	Jain Deepti	Director	2025-05-20	A	23,917	—	$0
2025-05-21	Berry Lance A	Director	2025-05-20	A	23,917	—	$0
2025-05-21	HAMILTON LAWRENCE W	Director	2025-05-20	A	23,917	—	$0
2025-05-21	Kiernan Jane E	Director	2025-05-20	A	23,917	—	$0
2025-05-21	Hanna Betsy	Director	2025-05-20	A	23,917	—	$0
2025-05-21	MOTT RICHARD W	Director	2025-05-20	A	23,917	—	$0
2025-05-21	BAKEWELL JOHN K	Director	2025-05-20	A	23,917	—	$0
2025-05-12	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-05-08	A	7,775	—	$0
2025-05-12	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-05-08	F	(1,894)	$7.54	-$14,281
2025-03-19	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-03-17	M	50,000	$1.05	$52,500
2025-03-19	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-03-17	S	(50,000)	$7.97	-$398,460
2025-03-19	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-03-17	M	(50,000)	—	$-0
2025-03-11	Berutti Aaron	Officer (SVP, Sales)	2025-03-10	F	(1,815)	—	$-0
2025-03-11	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2025-03-10	F	(5,021)	—	$-0
2025-03-11	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-03-10	F	(1,396)	—	$-0
2025-03-11	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-03-10	F	(1,675)	—	$-0
2025-03-11	Hair Mark	Officer (Chief Financial Officer)	2025-03-10	F	(3,684)	—	$-0
2025-03-11	Berutti Aaron	Officer (SVP, Sales)	2025-03-08	F	(728)	—	$-0
2025-03-11	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2025-03-08	F	(2,063)	—	$-0
2025-03-11	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-03-08	F	(401)	—	$-0
2025-03-11	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-03-08	F	(176)	—	$-0
2025-03-11	Hair Mark	Officer (Chief Financial Officer)	2025-03-08	F	(961)	—	$-0
2025-03-04	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2025-03-04	P	60,000	$8.73	$524,064
2025-01-24	Berutti Aaron	Officer (SVP, Sales)	2025-01-22	A	75,000	—	$0
2025-01-24	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-01-22	A	140,625	—	$0
2025-01-24	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-01-22	A	127,500	—	$0
2025-01-24	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2025-01-22	A	225,000	—	$0
2025-01-24	Hair Mark	Officer (Chief Financial Officer)	2025-01-22	A	187,500	—	$0
2025-01-14	Hair Mark	Officer (Chief Financial Officer)	2025-01-10	F	(8,594)	—	$-0
2025-01-14	Scanlan Sean F.	Officer (Chief Innovation Officer)	2025-01-10	F	(4,821)	—	$-0
2025-01-14	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2025-01-10	F	(4,544)	—	$-0
2025-01-14	Berutti Aaron	Officer (SVP, Sales)	2025-01-10	F	(4,821)	—	$-0
2025-01-14	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2025-01-10	F	(11,905)	—	$-0
2024-12-05	Guglielmino Guy	Officer (Chief Commercial Officer)	2024-12-01	A	330,000	—	$0
2024-12-05	Guglielmino Guy	Officer (Chief Commercial Officer)	2024-12-01	A	33,000	—	$0
2024-11-13	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2024-11-11	A	15,550	—	$0
2024-11-13	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2024-11-11	F	(3,787)	$8.29	-$31,394
2024-10-02	Elder Scot Michael	Officer (Chief Legl & Comp Off, CorpSec)	2024-09-30	A	200,000	—	$0
2024-09-17	Treace John T.	Director, Officer (Chief Executive Officer), 10% Owner	2024-09-16	P	50,000	$5.31	$265,630
2024-09-16	Scanlan Sean F.	Officer (Chief Innovation Officer)	2024-09-12	M	33,750	$0.10	$3,280
2024-09-16	Scanlan Sean F.	Officer (Chief Innovation Officer)	2024-09-12	M	(33,750)	—	$-0